Because of its involvement in the onset of several cancer pathologies and its functions solely based on mediating protein-protein interactions, a deep understanding of the mechanism of binding of Crkl with its ligands is of primary importance as a first step toward the definition of potential therapeutic strategies aimed to modulate those interactions. The gene discussed is CRKL; the disease is cancer.